TY - JOUR
T1 - Direct cellular peptidomics of hypothalamic neurons
AU - Mitchell, Jennifer W.
AU - Atkins, Norman
AU - Sweedler, Jonathan V.
AU - Gillette, Martha U.
N1 - Funding Information:
The project described was supported by award numbers P30 DA018310 from the National Institute on Drug Abuse (NIDA) to JVS, and HL086870 and HL092571 ARRA from the National Heart, Lung and Blood Institute (NHLBI) to MUG. We thank Maureen Holtz for preparing the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
PY - 2011/10
Y1 - 2011/10
N2 - The chemical complexity of cell-to-cell communication has emerged as a fundamental challenge to understanding brain systems. This is certainly true for the hypothalamus, where neuropeptide signals are heterogeneous, localized and dynamic. Thus far, most hypothalamic peptidomic studies have centered on the entire structure; however, recent advances in collection strategies and analytical technologies have enabled direct, high-resolution peptidomic profiles focused on two regions of interest, the suprachiasmatic and supraoptic nuclei, including their sub-regions and individual cells. Suites of peptides now can be identified and probed for function. High spatial and analytical sensitivities reveal that discrete hypothalamic nuclei have distinct peptidomic signatures. Peptidomic discovery not only reveals unanticipated complexity, but also peptides previously unknown that act as key circuit components. Analysis of tissue releasates identifies peptides secreted into the extracellular environment and available for transmitting intercellular signals. Direct sampling techniques define peptide-releasate profiles in spatial, temporal and event-dependent patterns. These approaches are providing remarkable new insights into the complexity of neuropeptidergic cell-to-cell signaling central to neuroendocrine physiology.
AB - The chemical complexity of cell-to-cell communication has emerged as a fundamental challenge to understanding brain systems. This is certainly true for the hypothalamus, where neuropeptide signals are heterogeneous, localized and dynamic. Thus far, most hypothalamic peptidomic studies have centered on the entire structure; however, recent advances in collection strategies and analytical technologies have enabled direct, high-resolution peptidomic profiles focused on two regions of interest, the suprachiasmatic and supraoptic nuclei, including their sub-regions and individual cells. Suites of peptides now can be identified and probed for function. High spatial and analytical sensitivities reveal that discrete hypothalamic nuclei have distinct peptidomic signatures. Peptidomic discovery not only reveals unanticipated complexity, but also peptides previously unknown that act as key circuit components. Analysis of tissue releasates identifies peptides secreted into the extracellular environment and available for transmitting intercellular signals. Direct sampling techniques define peptide-releasate profiles in spatial, temporal and event-dependent patterns. These approaches are providing remarkable new insights into the complexity of neuropeptidergic cell-to-cell signaling central to neuroendocrine physiology.
KW - Arginine vasopressin (AVP)
KW - Gastrin-releasing peptide (GRP)
KW - Hypothalamus
KW - Little SAAS
KW - Mass spectrometry (MS)
KW - Neuropeptide
KW - Peptidomics
KW - Suprachiasmatic nucleus (SCN)
KW - Supraoptic nucleus (SON)
KW - Vasoactive intestinal peptide (VIP)
UR - http://www.scopus.com/inward/record.url?scp=80053127564&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80053127564&partnerID=8YFLogxK
U2 - 10.1016/j.yfrne.2011.02.005
DO - 10.1016/j.yfrne.2011.02.005
M3 - Review article
C2 - 21334363
AN - SCOPUS:80053127564
SN - 0091-3022
VL - 32
SP - 377
EP - 386
JO - Frontiers in Neuroendocrinology
JF - Frontiers in Neuroendocrinology
IS - 4
ER -